American International Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-46,567
| Closed | -$208K | – | 115 |
|
|
2024
Q1 | $208K | Sell |
46,567
-400
| -0.9% | -$1.79K | ﹤0.01% | 2123 |
|
|
2023
Q4 | $151K | Buy |
46,967
+5,955
| +15% | +$19.1K | ﹤0.01% | 2324 |
|
|
2023
Q3 | $130K | Buy |
41,012
+1,459
| +4% | +$4.63K | ﹤0.01% | 2364 |
|
|
2023
Q2 | $197K | Buy |
39,553
+1,090
| +3% | +$5.42K | ﹤0.01% | 2177 |
|
|
2023
Q1 | $190K | Buy |
38,463
+765
| +2% | +$3.78K | ﹤0.01% | 2138 |
|
|
2022
Q4 | $237K | Sell |
37,698
-137
| -0.4% | -$862 | ﹤0.01% | 2043 |
|
|
2022
Q3 | $409K | Buy |
37,835
+534
| +1% | +$5.77K | ﹤0.01% | 1699 |
|
|
2022
Q2 | $425K | Buy |
37,301
+3,540
| +10% | +$40.3K | ﹤0.01% | 1714 |
|
|
2022
Q1 | $308K | Sell |
33,761
-2,376
| -7% | -$21.7K | ﹤0.01% | 1990 |
|
|
2021
Q4 | $539K | Sell |
36,137
-1,081
| -3% | -$16.1K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $957K | Sell |
37,218
-885
| -2% | -$22.8K | 0.01% | 1463 |
|
|
2021
Q2 | $994 | Buy |
38,103
+6,680
| +21% | +$174 | ﹤0.01% | 1513 |
|
|
2021
Q1 | $1.11K | Buy |
31,423
+83
| +0.3% | +$3 | ﹤0.01% | 1404 |
|
|
2020
Q4 | $791 | Sell |
31,340
-900
| -3% | -$23 | ﹤0.01% | 1518 |
|
|
2020
Q3 | $1.22M | Buy |
32,240
+2,572
| +9% | +$97K | 0.01% | 1155 |
|
|
2020
Q2 | $1.27M | Buy |
29,668
+6,706
| +29% | +$287K | 0.01% | 1113 |
|
|
2020
Q1 | $446K | Sell |
22,962
-1,326
| -5% | -$25.8K | ﹤0.01% | 1489 |
|
|
2019
Q4 | $631K | Sell |
24,288
-205
| -0.8% | -$5.33K | ﹤0.01% | 1565 |
|
|
2019
Q3 | $668K | Sell |
24,493
-171
| -0.7% | -$4.66K | ﹤0.01% | 1509 |
|
|
2019
Q2 | $662K | Buy |
24,664
+10,617
| +76% | +$285K | ﹤0.01% | 1543 |
|
|
2019
Q1 | $406K | Sell |
14,047
-31
| -0.2% | -$896 | ﹤0.01% | 1835 |
|
|
2018
Q4 | $379K | Buy |
+14,078
| New | +$379K | ﹤0.01% | 1825 |
|